In the dusty waiting room of a rural health center in central Malawi, a mother holds her two-year-old son on her lap. The child has a fever, has been vomiting, and has not eaten in two days. The nurse on duty, Grace Banda, takes a history and then gently presses on the boy's abdomen, feeling for the tip of the spleen. She does not reach for a rapid diagnostic test—there are none in stock. Instead, she makes a diagnosis by touch.

This scene is repeated daily across Malawi's health facilities, where rapid diagnostic tests for malaria run dry for weeks at a time. Nurses must rely on clinical judgment alone, using palpation for splenomegaly, fever pattern, and seasonal risk to diagnose malaria in children under five. It is a skill born of necessity, but it comes with trade-offs: speed of care against accuracy, and confidence against the risk of missing a bacterial infection.

When the Rapid Test Cupboard Is Bare

Malawi's health facilities have long struggled with stockouts of essential diagnostics. According to the country's Health Sector Strategic Plan, stockout rates for malaria rapid diagnostic tests (RDTs) have fluctuated between 10 and 30 percent at the facility level in recent years. In remote health centers, the situation is worse. Supply chain disruptions, transport delays, and underreporting in national figures mean that nurses often face weeks without a single test.

When the RDT cupboard is bare, nurses must decide: send a febrile child home untreated, refer to a distant hospital, or treat based on clinical signs. Most choose the latter. The World Health Organization's Integrated Management of Childhood Illness (IMCI) guidelines allow for clinical diagnosis in the absence of confirmatory tests, but the protocol assumes that a test will usually be available. In practice, nurses are left to improvise.

“We know the risk of overdiagnosis,” says Banda, who has worked at the health center for six years. “But if we send a child home and they die, the mother will not forgive us. So we treat.” The tension between the ideal of evidence-based medicine and the reality of resource-limited settings is palpable. Nurses are trained to follow algorithms, but when the algorithm depends on a test that is not there, they fall back on experience.

The problem is not unique to Malawi. Across sub-Saharan Africa, stockouts of RDTs and other diagnostics are a chronic issue. A 2024 study in the Malaria Journal found that RDT stockouts in 10 African countries lasted an average of 18 days per quarter. But Malawi's centralized supply chain, managed by the Central Medical Stores Trust, has been particularly slow to adapt to demand spikes during the rainy season.

In some districts, stockouts have become so predictable that nurses have developed informal workarounds. At a clinic in Salima district, for example, nurses keep a logbook of RDT availability and share information via mobile phone groups to anticipate shortages. When word gets out that a nearby facility has tests, mothers may travel long distances to seek care. This informal triage system, while resourceful, places additional burden on families and increases the risk of delayed treatment.

The Art of Palpating a Child's Spleen

Palpation for splenomegaly—a palpable spleen—is a cornerstone of clinical malaria diagnosis in children. In endemic areas, a child with fever and an enlarged spleen is highly likely to have malaria. The technique requires practice: the nurse must position the child on their back, flex the knees, and gently press the left upper quadrant during deep inspiration. A spleen tip felt below the costal margin signals chronic or repeated infection.

But splenomegaly is not specific to malaria. It can also result from schistosomiasis, sickle cell disease, or other infections. And in early malaria, the spleen may not be enlarged at all. Nurses must weigh the finding against other clues: the pattern of fever (paroxysmal every 48 hours for Plasmodium falciparum), the season (peak transmission during the rainy months), and the child's age (under five years at highest risk).

“We use all the information we have,” says nurse midwife Esther Phiri, who works in a clinic in Ntcheu district. “The mother tells me when the fever started, whether the child has been convulsing, whether they are lethargic. I check for pallor in the palms. If the spleen is big, I am confident it is malaria.” The IMCI protocol provides a simplified algorithm: fever plus splenomegaly equals malaria, treat with artemether-lumefantrine. No backup test for asymptomatic parasitemia is available.

The reliance on clinical judgment has limits. A child with a bacterial infection such as pneumonia or meningitis may also present with fever and sometimes splenomegaly. Without a diagnostic test, these infections can be misattributed to malaria, leading to delayed or inappropriate treatment. “We worry about missing a chest infection,” says Phiri. “But we have no way to check here. We only have a stethoscope.”

Nurses also rely on the mother's report of convulsions—a danger sign that may indicate cerebral malaria or another neurological condition. In the absence of a test, convulsions automatically trigger a referral to a higher-level facility, but transport is often unavailable or unaffordable. Families may have to walk or bicycle for hours, and some children die en route. The clinical exam, while valuable, cannot replace the speed and specificity of a diagnostic test.

How Malawi's Health System Reached This Point

The roots of the stockout crisis lie in a combination of global and local factors. Malawi's RDTs are largely procured through the Global Fund to Fight AIDS, Tuberculosis and Malaria, which supplies the tests in bulk. But supply chain disruptions—shipping delays, manufacturing bottlenecks, and customs clearance issues—can cause months-long gaps. At the national level, the Central Medical Stores Trust distributes tests to district health offices, which then deliver them to facilities. The system is prone to leakage, expiration, and last-mile delivery failures.

Transport is a major bottleneck. Many health centers are accessible only by dirt roads that become impassable during the rainy season. A district health office may have only one vehicle for deliveries, and fuel is often rationed. As a result, facilities may go weeks without resupply even if tests are available at the district level. Stockout data is often underreported: facilities may not submit reports on time, or they may overstate their stock to avoid scrutiny.

Nurses have adapted by training themselves to improvise. Clinical officers—mid-level practitioners with three years of training—often mentor nurses in palpation and history-taking. “We have learned to trust our hands,” says Banda. But the improvisation comes at a cost. A 2023 study in BMJ Global Health estimated that clinical diagnosis of malaria in children under five in sub-Saharan Africa has a sensitivity of around 80 percent and specificity of 50–60 percent, meaning that many children without malaria are treated, and some with malaria are missed.

The Malawian government has acknowledged the problem. The Health Sector Strategic Plan 2023–2030 includes targets to reduce stockout rates and improve supply chain visibility. But progress has been slow. Meanwhile, nurses continue to diagnose by touch, hoping that their hands are accurate enough.

A deeper issue is the chronic underfunding of the health system. Malawi spends roughly US$ 30–40 per person per year on health, far below the World Health Organization's recommended minimum of US$ 86. This funding gap means that even when RDTs are available, other essentials—such as antibiotics, pain relievers, and basic laboratory supplies—are often missing. Nurses must prioritize, and malaria treatment often takes precedence because of its high prevalence and rapid lethality in children.

The Hidden Cost of Empiric Treatment

Treating malaria without a positive test—empiric treatment—carries several risks. The most immediate is overdiagnosis: children who do not have malaria receive antimalarials unnecessarily, wasting drugs that are already in short supply. In some clinics, nurses report that they treat every febrile child with artemether-lumefantrine during the rainy season, regardless of clinical signs. This practice drives up costs and can contribute to drug pressure, potentially accelerating the emergence of artemisinin resistance.

More concerning is the risk of missed or delayed diagnosis of other febrile illnesses. Pneumonia, meningitis, urinary tract infections, and sepsis all present with fever in children. Without a diagnostic test to rule out malaria, nurses may attribute the fever to malaria and send the child home with antimalarials, only for the underlying infection to worsen. “We see children come back with severe pneumonia who were treated for malaria the week before,” says Dr. Charles Mwansambo, a pediatrician at Kamuzu Central Hospital in Lilongwe.

Parental trust also erodes when fever is ignored or misdiagnosed. A mother whose child is told they have malaria but does not improve may lose faith in the health system. Some families turn to traditional healers or private drug sellers, who often provide incomplete or inappropriate treatment. The cycle of mistrust and self-medication further complicates disease management.

Drug resistance is a long-term threat. The World Health Organization has warned that overuse of antimalarials can select for resistant parasites. While artemisinin resistance has not been confirmed in Malawi, it has emerged in neighboring countries. Empiric treatment, especially when based on clinical signs alone, increases the volume of drug use and the selection pressure on parasites.

There is also an economic cost. Each course of artemether-lumefantrine costs the health system roughly US$ 1–2, a significant sum when multiplied across hundreds of thousands of febrile episodes. When tests are unavailable, the wastage is unavoidable, but it strains already tight budgets. Some districts have experimented with restricting empiric treatment to children under five only, but this policy is difficult to enforce when nurses face pressure from desperate parents.

Training Nurses to Trust Their Hands

Recognizing that stockouts will not be solved overnight, Malawi has invested in training nurses to improve the accuracy of clinical diagnosis. The Ministry of Health, with support from partners such as the WHO and UNICEF, runs a “clinical mentorship” program that sends senior clinical officers to rural health centers for on-site coaching. During these visits, mentors observe consultations, provide feedback, and review cases with nurses.

The program emphasizes the importance of a structured clinical exam: palpating the spleen, assessing for pallor, checking for respiratory distress, and taking a thorough history. Nurses are taught to use simplified algorithms that integrate signs and symptoms to guide treatment decisions. For example, a child with fever, splenomegaly, and no respiratory signs is likely malaria; a child with fever, fast breathing, and chest indrawing is likely pneumonia.

Community health workers, known as Health Surveillance Assistants (HSAs) in Malawi, also play a role. They are trained to test for malaria using RDTs when available, and to refer children with danger signs. But when RDTs are out of stock at the health center, HSAs often face the same dilemma. The mentorship program has helped align the referral criteria between HSAs and nurses, creating a more consistent approach to fever management.

Nurses report increased confidence in tactile diagnosis after mentorship. “Before, I was afraid to treat without a test,” says Phiri. “Now I know what to feel for. I can tell the mother that her child has malaria, and I believe it.” But even the best clinical exam cannot replace a diagnostic test. The mentorship program is a stopgap, not a solution.

Some nurses have also developed their own decision-support tools. At a clinic in Machinga district, a nurse created a laminated card with a simplified algorithm that includes space for RDT results when available. The card is used to standardize the exam and ensure no step is missed. Such innovations, while limited in scope, demonstrate the resourcefulness of frontline health workers.

Beyond Stockouts: Systemic Fixes Needed

Solving the problem of stockouts requires more than training. It requires investment in real-time supply chain data systems that can track RDT stock levels at every facility and trigger resupply before a stockout occurs. Several pilot projects in Malawi are testing electronic logistics management information systems, but they have not been scaled nationally. Decentralizing procurement to the district level could also help, allowing districts to purchase tests directly from suppliers when central stocks run low.

Expanding point-of-care diagnostics beyond malaria is another priority. A febrile child could have any of several infections, and a single test for malaria is not enough. Multiplex tests that can detect malaria, typhoid, dengue, and other pathogens are being developed, but they remain expensive and not yet widely available in Malawi. Investment in such technologies could reduce the reliance on clinical judgment and improve outcomes.

Strengthening nurse oversight and decision-support tools is also critical. Nurses in rural clinics often work alone and must make high-stakes decisions without supervision. Simple decision-support algorithms, delivered via mobile phone or paper chart, could help standardize care and reduce errors. The WHO's IMCI guidelines already provide such tools, but they need to be adapted to the reality of frequent stockouts.

Malawi's Health Sector Strategic Plan targets for 2030 include reducing RDT stockout rates to below five percent and increasing the proportion of febrile children who receive a diagnostic test. These are ambitious goals, and achieving them will require sustained political will and funding. Until then, nurses in rural clinics will continue to diagnose by touch—a skill that saves lives, but also carries risk.

As Banda puts it: “I hope one day we will have enough tests. But until then, I will use my hands. What else can I do?”

This article is for informational purposes only and does not constitute medical advice. Readers should consult qualified health professionals for diagnosis and treatment.